IL Pharmacy Resident Conference
Save the Date! May 21, 2027 at Roosevelt University, Schaumburg, IL
In-person!
******
Did you miss out on the 2026 ILPRC? Check out the 2026 conference objectives and keynote speaker information!
Plan on joining us in 2027!
2026 ILPRC General Learning Objectives for the conference:
May 29, 2026
1. Examine evidence-based approaches for the treatment and management of diverse disease states.
2. Analyze variations in clinical workflows and protocols across multiple health-system environments.
3. Discuss current and emerging evidence impacting clinical decision-making.
4. Outline effective clinical and administrative interventions that improve patient care and operational efficiency.
All ILPRC presentations are accredited for CE!
*****
2026 Opening Keynote Speaker
Dr. Dawn M. Moore, PharmD, MS, CPEL, FACHE, FISHP
Vice President & Chief Pharmacy Officer
Community Health Network
"Navigating Your Leadership Journey: Career Insights and Practical Advice for New Practitioners"
*****
2026 Presentation abstracts available under Abstracts & Presenters tab - Conclusions were presented at the ILPRC Conference.
2026 Meeting Abstracts
2026 Abstracts & Presenters
2026 Meeting Materials - as example ONLY
2026 ILPRC Syllabus - as pdf
2026 ILPRC Continuing Education Information
Joint Providership Statement:
In support of improving patient care, this activity has been planned and implemented by RUSH University Medical Center and Illinois council of Health-System Pharmacists. RUSH University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity is being presented without bias and without commercial support.
2026 Credit Designation Statements
For Pharmacy:
RUSH University Medical Center designates this knowledge-based activity for a maximum of 6.75 contact hour(s) for pharmacists.
2026 ACTIVITY UAN # JA0000275-9999-26-099-L01-P
To claim Continuing Education Credit, attendees must:
- Attend the entire session.
- Evaluate and generate a certificate according to the instructions in your syllabus.
Disclosure Information
Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.
It is the policy of the Interprofessional Continuing Education office at RUSH University Medical Center to manage all financial relationships associated with accredited continuing education activities. This management includes oversight of grant funding (including right to review and co-sign Letters of Agreement), exhibitors (including right to review and co-sign contracts/letters of agreement) and the relevant financial relationships of activity faculty. RUSH asks everyone who has the ability to control or influence the content of an educational activity to disclose information about all of their financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies. Individuals must disclose regardless of their view of the relevance of the relationship to education. Mechanisms are in place to identify and mitigate any potential conflicts of interest prior to the start of the activity.
Individuals in control of content for this activity have disclosed any relevant financial relationships and all financial relationships have been mitigated. Disclosures are on the presentation slides.
2026 DISCLOSURES
• Esha Bhargava (Preceptor) - Bayer AG - Consultant
• Drew Halbur (Preceptor) - Gilead Sciences, Inc, ViiV Healthcare - Educational speaker on injectable PrEP products
• Caleb Rux (Preceptor) - Shionogi Inc. - Advisor
• Michael Schmidt (Preceptor) - Syndax Pharmaceuticals - Stockholder/Options
• Pamela Simone (Preceptor) - Mineralys Therapeutics - Independent contractor
All other individuals in control of content have no financial relationships with ineligible companies.
Roosevelt University
1400 N. Roosevelt Blvd
Schaumburg, IL 60173
In-person!
Additional events that may be planned to coincide at the ILPRC by ICHP networks or members will be posted here.
ILPRC is coordinated by the Illinois Council of Health-System Pharmacists with special volunteer support of the ICHP Residency Leaders Network and ICHP Student Volunteers.
2026 had no outside sponsor.
